Open access
Sep 2026
CCR4+low-density neutrophils define a novel immunosuppressive subset associated with breast cancer progression and early mortality
A distinct neutrophil population that actively contributes to immune escape and tumor progression is revealed, establishing CCR4+LDN as a minimally invasive real-time biomarker of disease course and treatment response, and as a promising target for neutrophil-directed therapies in BC.
Bruna F. Correia, D. Grosa, R. Salvador et al.
· bioRxiv · 0 citations